Reeve B. Waud - May 18, 2023 Form 4 Insider Report for Acadia Healthcare Company, Inc. (ACHC)

Role
Director
Signature
/s/ Reeve B. Waud
Stock symbol
ACHC
Transactions as of
May 18, 2023
Transactions value $
$241,970
Form type
4
Date filed
5/19/2023, 05:05 PM
Previous filing
May 20, 2022
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACHC Common Stock, par value $0.01 per share Award $0 +2.23K +7.28% $0.00 32.8K May 18, 2023 Direct F1
transaction ACHC Common Stock, par value $0.01 per share Award $242K +3.37K +10.26% $71.78 36.2K May 18, 2023 Direct F2
holding ACHC Common Stock, par value $0.01 per share 507K May 18, 2023 See Footnotes F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares will vest over a 3-year period in equal annual installments beginning May 18, 2024.
F2 Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2023 in shares of common stock.
F3 The shares are owned of record as follows: (i) 157,491 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the 2012 RBW Jr Family Trust, and (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust").
F4 Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.
F5 Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.